Its presence in amyloid-filled brain regions, association with cerebral atrophy, and correlation with cognitive impairment across various inflammatory conditions, including RA, stroke, and periodontitis, reinforces the hypothesis that systemic inflammation, mediated in part by CRP, may accelerate or trigger neurodegeneration. The gene discussed is CRP; the disease is rheumatoid arthritis.